1.Schouten, MA, et al. Prevalence of vancomycin-resistant enterococci in Europe. European Journal of Clinical Microbiology and Infectious Diseases 2000; 19: 816–822.
2.Burger, T, et al. Multihospital surveillance of nosocomial methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, and Clostridium difficile: analysis of a 4-year data-sharing project, 1999–2002. American Journal of Infection Control 2006; 34: 458–464.
3.Werner, G, et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Eurosurveillance 2008; 13.
4.Vincent, S, et al. Vancomycin susceptibility and identification of motile enterococci. Journal of Clinical Microbiology 1991; 29: 2335–2337.
5.Leclercq, R, et al. Vancomycin resistance gene vanC is specific to Enterococcus gallinarum. Antimicrobial Agents and Chemotherapy 1992; 36: 2005–2008.
6.Dutka-Malen, S, et al. Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrobial Agents and Chemotherapy 1994; 38: 1675–1677.
7.Van Horn, KG, Rodney, KM. Colonization and microbiology of the motile enterococci in a patient population. Diagnostic Microbiology and Infectious Disease 1998; 31: 525–530.
8.Toye, B, et al. Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype). Journal of Clinical Microbiology 1997; 35: 3166–3170.
9.Patel, R, et al. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci. Journal of Clinical Microbiology 1997; 35: 703–707.
10.Liassine, N, et al. Characterization of glycopeptide-resistant enterococci from a Swiss hospital. Journal of Clinical Microbiology 1998; 36: 1853–1858.
11.Mammina, C, et al. VanB-VanC1 Enterococcus gallinarum, Italy. Emerging Infectious Disease 2005; 11: 1491–1492.
12.Biavasco, F, et al. VanA-type enterococci from humans, animals, and food: species distribution, population structure, Tn1546 typing and location, and virulence determinants. Applied and Environmental Microbiology 2007; 73: 3307–3319.
13.Biavasco, F, et al. Recovery from a single blood culture of two Enterococcus gallinarum isolates carrying both vanC-1 and vanA cluster genes and differing in glycopeptide susceptibility. European Journal of Clinical Microbiology and Infectious Diseases 2001; 20: 309–314.
14.Merquior, VL, et al. Bacteraemia associated with a vancomycin-resistant Enterococcus gallinarum strain harbouring both the vanA and vanC1 genes. Journal of Medical Microbiology 2008; 57: 244–245.
15.Corso, A, et al. First report of VanA Enterococcus gallinarum dissemination within an intensive care unit in Argentina. International Journal of Antimicrobial Agents 2005; 25: 51–56.
16.Neves, FP, et al. Emergence of the vanA genotype among Enterococcus gallinarum isolates colonising the intestinal tract of patients in a university hospital in Rio de Janeiro, Brazil. International Journal of Antimicrobial Agents 2009; 33: 211–215.
17.Uzawa, Y, et al. A novel selective medium for screening for VanA and VanB glycopeptide-resistant enterococci in feces. In: 102nd American Society for Microbiology General Meeting. Salt Lake City, Utah: American Society for Microbiology, 2002.
18.Kariyama, R, et al. Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. Journal of Clinical Microbiology 2000; 38: 3092–3095.
19.Elsayed, S, et al. Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp. Journal of Clinical Microbiology 2001; 39: 2367–2368.
20.Cartwright, CP, et al. Comparison of pigment production and motility tests with PCR for reliable identification of intrinsically vancomycin-resistant enterococci. Journal of Clinical Microbiology 1995; 33: 1931–1933.
21.Clark, NC, et al. Detection and differentiation of vanC-1, vanC-2, and vanC-3 glycopeptide resistance genes in enterococci. Journal of Clinical Microbiology 1998; 36: 2294–2297.
22.Turabelidze, D, et al. Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. Journal of Clinical Microbiology 2000; 38: 4242–4245.
23.Duck, WM, et al. Optimization of computer software settings improves accuracy of pulsed-field gel electrophoresis macrorestriction fragment pattern analysis. Journal of Clinical Microbiology 2003; 41: 3035–3042.
24.Morrison, D, et al. DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains. Journal of Clinical Microbiology 1999; 37: 1084–1091.
25.Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. M100-S19. Clinical and Laboratory Standards Institute, Wayne, Pa 2009.
26.Messi, P, et al. Vancomycin-resistant enterococci (VRE) in meat and environmental samples. International Journal of Food Microbiology 2006; 107: 218–222.
27.Roberts, MC, et al. Vancomycin-resistant Enterococcus spp. in marine environments from the West Coast of the USA. Journal of Applied Microbiology 2009; 107: 300–307.
28.Foglia, G, et al. Molecular analysis of Tn1546-like elements mediating high-level vancomycin resistance in Enterococcus gallinarum. Journal of Antimicrobial Chemotherapy 2003; 52: 772–775.
29.Reid, KC, Cockerill, IF, Patel, R. Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clinical Infectious Diseases 2001; 32: 1540–1546.
30.Choi, SH, et al. Clinical features and outcomes of bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum: analysis of 56 cases. Clinical Infectious Diseases 2004; 38: 53–61.
31.Dargere, S, et al. Enterococcus gallinarum endocarditis occurring on native heart valves. Journal of Clinical Microbiology 2002; 40: 2308–2310.
32.Cooper, MP, et al. Outbreak of Enterococcus gallinarum infections after total knee arthroplasty. Infection Control and Hospital Epidemiology 2008; 29: 361–363.
33.Koganemaru, H, Hitomi, S. Bacteremia caused by VanC-type enterococci in a university hospital in Japan: a 6-year survey. Journal of Infection and Chemotherapy 2008; 14: 413–417.